bioAffinity Technologies, Inc. (BIAFW) stock
BIAFWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 4/3056% below fair value
$0.24+0.00 (0.00%)
Close on Oct 30, 2026Market cap $23.58MP/E –Yield –
bioAffinity Technologies enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
bioAffinity Technologies's enterprise value was $21.42M on Oct 19, 2026, against $34.10M a year earlier. Over the last 4 years it ranged from $21.42M to $416.53M, with a median of $182.65M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $21.42M | -60.3% |
| 2025 | Dec 31, 2025 | $53.98M | -70.4% |
| 2024 | Dec 31, 2024 | $182.65M | -8.1% |
| 2023 | Dec 29, 2023 | $198.80M | +6.1% |
| 2022 | Dec 30, 2022 | $187.39M | – |